Rui Jin Hospital - Shanghai Jiao Tong University School of Medicine
Shanghai, China
NCT Number: NCT01373541
The purpose of this study is to determine the effect of infant formula with high percentage of palmitic acid at the sn-2 position (InFat™) on improving fat absorption and general gastrointestinal tolerance in Chinese formula-fed term infants.
Looking for future studies?
Notify Me1 day–14 day
All sexes
Interventional
Not applicable
Shanghai, China
The purpose of this study is to assess the efficacy of infant formula with high percentage of palmitic acid at the sn-2 position (InFat™) as compared to standard vegetable oil based infant formula on general gastrointestinal tolerance and fat absorption, reducing calcium soaps formation and stool hardness in Chinese formula-fed term infants.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
high sn-2 palmitic acid oil based infant formula
Other names: high sn-2 palmitic acid, structured triglyceride
standard vegetable oil based infant formula
Other names: standard vegetable oil
Time frame: 6 postnatal weeks
Time frame: Baseline, 6, 12 and 24 postnatal weeks
Time frame: 6, 12 and 24 postnatal weeks
Time frame: Baseline, 6,12 and 24 postnatal weeks
Time frame: Baseline, 6,12 and 24 postnatal weeks
Enzymotec
Industry
Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China: a Double Blind, Multi-center, Randomized, Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04165473
Behavior, Behavioral Symptoms
Vienna, Austria
View Trial DetailsNCT05760001
Behavior, Behavioral Symptoms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06690554
Behavior, Disorders of Environmental Origin
Konya, Turkey (Türkiye)
View Trial DetailsNCT07566143
Adherence Interventions, Aging
Van, Turkey (Türkiye)
View Trial Details